Why trials lose participants: A multitrial investigation of participants perspectives using the theoretical domains framework
Newlands, R., Duncan, E., Presseau, J. , Treweek, S., Lawrie, L., Bower, P., Elliott, J., Francis, J. J. ORCID: 0000-0001-5784-8895, MacLennan, G., Ogden, M., Wells, M., Witham, M. D., Young, B. & Gillies, K. (2021). Why trials lose participants: A multitrial investigation of participants perspectives using the theoretical domains framework. Journal of Clinical Epidemiology, 137, pp. 1-13. doi: 10.1016/j.jclinepi.2021.03.007
Abstract
Objectives
To use the Theoretical Domains Framework (TDF) to identify barriers and enablers to participant retention in trials requiring questionnaire return and/or attendance at follow-up clinics.
Study design and setting
We invited participants (n = 607) from five pragmatic effectiveness trials, who missed at least one follow-up time point (by not returning a questionnaire and/or not attending a clinic visit), to take part in semistructured telephone interviews. The TDF informed both data collection and analysis. To establish what barriers and enablers most likely influence the target behavior the domain relevance threshold was set at >75% of participants mentioning the domain.
Results
Sixteen participants (out of 25 showing interest) were interviewed. Overall, seven theoretical domains were identified as both barriers and enablers to the target behaviors of attending clinic appointments and returning postal questionnaires. Barriers frequently reported in relation to both target behaviours stemmed from participants’ knowledge, beliefs about their capabilities and the consequences of performing (or not performing) the behavior. Two domains were identified as salient for questionnaire return only: goals; and memory, attention and decision-making. Emotion was identified as relevant for clinic attendance only.
Conclusion
This is the first study informed by behavioural science to explore trial participants’ accounts of trial retention. Findings will serve as a guiding framework when designing trials to limit barriers and enhance enablers of retention within clinical trials.
Publication Type: | Article |
---|---|
Additional Information: | © 2021 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
Subjects: | H Social Sciences > HA Statistics R Medicine > RA Public aspects of medicine |
Departments: | School of Health & Psychological Sciences |
SWORD Depositor: |
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (2MB) | Preview
Export
Downloads
Downloads per month over past year